311 related articles for article (PubMed ID: 10518130)
1. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
Sakuma N; Kamei T; Ishihara T
Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
[TBL] [Abstract][Full Text] [Related]
2. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
3. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
Warhol MJ; Hickey WF; Corson JM
Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
[TBL] [Abstract][Full Text] [Related]
4. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
5. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
Dewar A; Valente M; Ring NP; Corrin B
J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
[TBL] [Abstract][Full Text] [Related]
6. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
Yang GC
Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
[TBL] [Abstract][Full Text] [Related]
7. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
8. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
9. Freeze-fracture study of intercellular junctions in benign and malignant mesothelial cells in effusions and a comparison with those seen in pleural mesotheliomas (solid tumour).
Mukherjee TM; Swift JG; Henderson DW
J Submicrosc Cytol Pathol; 1988 Jan; 20(1):195-208. PubMed ID: 3370618
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural studies of cells in body cavity effusions.
Bewtra C; Greer KP
Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
[TBL] [Abstract][Full Text] [Related]
11. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of poorly differentiated diffuse epithelial mesotheliomas.
Dardick I; Al-Jabi M; McCaughey WT; Srigley JR; van Nostrand AW; Ritchie AC
Ultrastruct Pathol; 1984; 7(2-3):151-60. PubMed ID: 6085430
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural histochemistry of mesotheliomas and adenocarcinomas in malignant effusions.
Barsotti P; Muda AO; Ascoli V; Casareale P; Nardi F
Diagn Cytopathol; 1989; 5(2):154-61. PubMed ID: 2776597
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructure of diffuse malignant mesothelioma of the pleura. An analysis of ten cases.
Wasilewska A; Ryś J; Niezabitowski A
Patol Pol; 1993; 44(2):95-100. PubMed ID: 8367214
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructurally "invasive" microvilli in an aggressively metastasizing biphasic malignant mesothelioma.
Zu Y; Sidhu GS; Wieczorek R; Cassai ND
Ultrastruct Pathol; 2002; 26(6):403-9. PubMed ID: 12537765
[TBL] [Abstract][Full Text] [Related]
17. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
18. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
Kobzik L; Antman KH; Warhol MJ
Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
[TBL] [Abstract][Full Text] [Related]
19. Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells.
Dardick I; Butler EB; Dardick AM
Acta Cytol; 1986; 30(4):379-84. PubMed ID: 3461648
[TBL] [Abstract][Full Text] [Related]
20. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
